These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 25281926)

  • 1. Involvement of lysosomal degradation in VEGF-C-induced down-regulation of VEGFR-3.
    Han KY; Chang JH; Dugas-Ford J; Alexander JS; Azar DT
    FEBS Lett; 2014 Nov; 588(23):4357-63. PubMed ID: 25281926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The tyrosine kinase inhibitor cediranib blocks ligand-induced vascular endothelial growth factor receptor-3 activity and lymphangiogenesis.
    Heckman CA; Holopainen T; Wirzenius M; Keskitalo S; Jeltsch M; Ylä-Herttuala S; Wedge SR; Jürgensmeier JM; Alitalo K
    Cancer Res; 2008 Jun; 68(12):4754-62. PubMed ID: 18559522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RNAi-mediated silencing of VEGF-C inhibits non-small cell lung cancer progression by simultaneously down-regulating the CXCR4, CCR7, VEGFR-2 and VEGFR-3-dependent axes-induced ERK, p38 and AKT signalling pathways.
    Feng Y; Hu J; Ma J; Feng K; Zhang X; Yang S; Wang W; Zhang J; Zhang Y
    Eur J Cancer; 2011 Oct; 47(15):2353-63. PubMed ID: 21680174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Total saponins of panaxnotoginseng promotes lymphangiogenesis by activation VEGF-C expression of lymphatic endothelial cells.
    Li J; Chen Y; Zhang L; Xing L; Xu H; Wang Y; Shi Q; Liang Q
    J Ethnopharmacol; 2016 Dec; 193():293-302. PubMed ID: 27553977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sunitinib inhibits lymphatic endothelial cell functions and lymph node metastasis in a breast cancer model through inhibition of vascular endothelial growth factor receptor 3.
    Kodera Y; Katanasaka Y; Kitamura Y; Tsuda H; Nishio K; Tamura T; Koizumi F
    Breast Cancer Res; 2011 Jun; 13(3):R66. PubMed ID: 21693010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular controls of lymphatic VEGFR3 signaling.
    Deng Y; Zhang X; Simons M
    Arterioscler Thromb Vasc Biol; 2015 Feb; 35(2):421-9. PubMed ID: 25524775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. VEGFR-3 signaling is regulated by a G-protein activator, activator of G-protein signaling 8, in lymphatic endothelial cells.
    Sakima M; Hayashi H; Mamun AA; Sato M
    Exp Cell Res; 2018 Jul; 368(1):13-23. PubMed ID: 29649427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential Receptor Binding and Regulatory Mechanisms for the Lymphangiogenic Growth Factors Vascular Endothelial Growth Factor (VEGF)-C and -D.
    Davydova N; Harris NC; Roufail S; Paquet-Fifield S; Ishaq M; Streltsov VA; Williams SP; Karnezis T; Stacker SA; Achen MG
    J Biol Chem; 2016 Dec; 291(53):27265-27278. PubMed ID: 27852824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-6 Induces Vascular Endothelial Growth Factor-C Expression via Src-FAK-STAT3 Signaling in Lymphatic Endothelial Cells.
    Huang YH; Yang HY; Huang SW; Ou G; Hsu YF; Hsu MJ
    PLoS One; 2016; 11(7):e0158839. PubMed ID: 27383632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. VEGF and thrombin induce MKP-1 through distinct signaling pathways: role for MKP-1 in endothelial cell migration.
    Kinney CM; Chandrasekharan UM; Mavrakis L; DiCorleto PE
    Am J Physiol Cell Physiol; 2008 Jan; 294(1):C241-50. PubMed ID: 18003751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. VEGFR-3 controls tip to stalk conversion at vessel fusion sites by reinforcing Notch signalling.
    Tammela T; Zarkada G; Nurmi H; Jakobsson L; Heinolainen K; Tvorogov D; Zheng W; Franco CA; Murtomäki A; Aranda E; Miura N; Ylä-Herttuala S; Fruttiger M; Mäkinen T; Eichmann A; Pollard JW; Gerhardt H; Alitalo K
    Nat Cell Biol; 2011 Sep; 13(10):1202-13. PubMed ID: 21909098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contribution of macrophages to angiogenesis induced by vascular endothelial growth factor receptor-3-specific ligands.
    Chung ES; Chauhan SK; Jin Y; Nakao S; Hafezi-Moghadam A; van Rooijen N; Zhang Q; Chen L; Dana R
    Am J Pathol; 2009 Nov; 175(5):1984-92. PubMed ID: 19808642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD34+ VEGFR-3+ progenitor cells have a potential to differentiate towards lymphatic endothelial cells.
    Tan YZ; Wang HJ; Zhang MH; Quan Z; Li T; He QZ
    J Cell Mol Med; 2014 Mar; 18(3):422-33. PubMed ID: 24450475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ligand-induced vascular endothelial growth factor receptor-3 (VEGFR-3) heterodimerization with VEGFR-2 in primary lymphatic endothelial cells regulates tyrosine phosphorylation sites.
    Dixelius J; Makinen T; Wirzenius M; Karkkainen MJ; Wernstedt C; Alitalo K; Claesson-Welsh L
    J Biol Chem; 2003 Oct; 278(42):40973-9. PubMed ID: 12881528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of the VEGFR-3 pathway by VEGF-C attenuates UVB-induced edema formation and skin inflammation by promoting lymphangiogenesis.
    Kajiya K; Sawane M; Huggenberger R; Detmar M
    J Invest Dermatol; 2009 May; 129(5):1292-8. PubMed ID: 19005491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. VEGF-C alters barrier function of cultured lymphatic endothelial cells through a VEGFR-3-dependent mechanism.
    Breslin JW; Yuan SY; Wu MH
    Lymphat Res Biol; 2007; 5(2):105-13. PubMed ID: 17935478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymphangiogenesis in aortic valve stenosis--novel regulatory roles for valvular myofibroblasts and mast cells.
    Syväranta S; Helske S; Lappalainen J; Kupari M; Kovanen PT
    Atherosclerosis; 2012 Apr; 221(2):366-74. PubMed ID: 22281299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of lymphangiogenesis in human lymphatic endothelial cells by simultaneously blocking VEGF-C and VEGF-D/VEGFR-3 with norcantharidin.
    Liu ZY; Qiu HO; Yuan XJ; Ni YY; Sun JJ; Jing W; Fan YZ
    Int J Oncol; 2012 Nov; 41(5):1762-72. PubMed ID: 22922710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD146 is required for VEGF-C-induced lymphatic sprouting during lymphangiogenesis.
    Yan H; Zhang C; Wang Z; Tu T; Duan H; Luo Y; Feng J; Liu F; Yan X
    Sci Rep; 2017 Aug; 7(1):7442. PubMed ID: 28785085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Slit2N and Robo4 regulate lymphangiogenesis through the VEGF-C/VEGFR-3 pathway.
    Yu J; Zhang X; Kuzontkoski PM; Jiang S; Zhu W; Li DY; Groopman JE
    Cell Commun Signal; 2014 Apr; 12():25. PubMed ID: 24708522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.